Can Nephrectomy or Brain Tumor Cause Low Phosphorus?
Yes, a brain tumor can cause hypophosphatemia through tumor-induced osteomalacia (TIO), but nephrectomy itself does not directly cause low phosphorus—rather, it removes the kidney's ability to regulate phosphate, which could worsen pre-existing hypophosphatemia or alter phosphate homeostasis.
Brain Tumors and Hypophosphatemia
Brain tumors, particularly phosphaturic mesenchymal tumors located in the skull or brain, are a recognized cause of hypophosphatemia through excessive FGF23 production 1. These tumors can occur in the temporo-occipital bone and other cranial locations 2.
Mechanism of Tumor-Induced Osteomalacia:
- FGF23 overproduction by mesenchymal tumors causes renal phosphate wasting, leading to severe hypophosphatemia 3, 4
- The tumor secretes FGF23, which inhibits proximal tubular phosphate reabsorption and suppresses 1,25-dihydroxyvitamin D synthesis
- This results in hyperphosphaturia (elevated urine phosphate excretion), hypophosphatemia, and inappropriately low or normal 1,25-vitamin D levels 4
Key Diagnostic Features:
- Elevated or inappropriately normal intact FGF23 levels in the setting of hypophosphatemia (normally FGF23 should be suppressed when phosphate is low) 1
- Fractional excretion of phosphate (FEPO4) >5% indicates renal phosphate wasting 4
- 24-hour urine phosphate >100 mg/day despite hypophosphatemia 4
- Important caveat: Use intact FGF23 assays rather than C-terminal assays for better diagnostic accuracy 4
Clinical Presentation:
Patients present with bone pain, fractures, muscle weakness, and osteomalacia. Surgical resection of the tumor leads to normalization of phosphate levels and complete clinical recovery 2, 3.
Nephrectomy and Phosphate Regulation
Nephrectomy does not cause hypophosphatemia through a direct mechanism. However, important considerations include:
- The kidneys are the primary site of phosphate regulation through proximal tubular reabsorption
- Removing one kidney (unilateral nephrectomy) typically allows the remaining kidney to compensate adequately
- Bilateral nephrectomy or progression to kidney failure would lead to hyperphosphatemia (high phosphorus), not hypophosphatemia, due to inability to excrete phosphate
When to Consider Renal Causes of Hypophosphatemia:
The guidelines emphasize that renal phosphate wasting can occur through:
- Primary renal tubular defects (Fanconi syndrome, Dent disease) 1
- These conditions show low or suppressed FGF23 levels (unlike TIO where FGF23 is elevated)
- Exclude metabolic acidosis, hypercalciuria, and generalized proximal tubular dysfunction by checking serum bicarbonate, urinary calcium, amino acids, glucose, and low-molecular-weight proteins 1
Differential Diagnosis Algorithm
When evaluating hypophosphatemia:
Measure intact FGF23 levels alongside phosphate, PTH, 25-OH vitamin D, 1,25-OH vitamin D, and spot/24-hour urine phosphate 1
If FGF23 is elevated or inappropriately normal (not suppressed):
If FGF23 is suppressed (low):
- Consider primary renal tubular disorders (Fanconi syndrome, Dent disease) 1
- Evaluate for vitamin D deficiency, malabsorption, or nutritional causes
Additional cancer-related causes to consider:
Common Pitfalls
- Using C-terminal FGF23 assays instead of intact FGF23: C-terminal assays may miss TIO diagnosis 4
- Assuming recent IV iron (ferric carboxymaltose) rules out TIO: While IV iron can cause transient hypophosphatemia through FGF23 elevation, persistent hypophosphatemia months after exposure warrants TIO workup 4
- Missing occult tumors: Phosphaturic mesenchymal tumors are often small and difficult to localize, requiring specialized imaging 3, 4
- Confusing nephrectomy effects: Post-nephrectomy patients with remaining kidney function should not develop hypophosphatemia from the surgery itself